Skip to main content

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in CTNM — Contineum Therapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in CTNM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,508,803
+$1,628,046 QoQ
Shares Held
214,082
+48.7% QoQ
Ownership
0.569%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 101 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CTNM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. CTNM ranks #162 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CTNM

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,508,803 214,082
2026-03-31 $1,880,757 144,009
2025-12-31 $1,257,997 110,061
2025-09-30 $1,294,591 110,178
2025-06-30 $103,374 26,039
2025-03-31 $357,389 51,202
2024-12-31 $810,584 55,330
2024-09-30 $828,666 43,295
2024-06-30 $911,704 51,772